These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7401102)

  • 1. Antiinflammatory effects of some copper complexes.
    Brown DH; Smith WE; Teape JW; Lewis AJ
    J Med Chem; 1980 Jul; 23(7):729-34. PubMed ID: 7401102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the antiinflammatory activities of copper complexes in different models of inflammation.
    Lewis AJ; Smith WE; Brown DH
    Agents Actions Suppl; 1981; 8():327-38. PubMed ID: 6937128
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of the anti-inflammatory effects of copper aspirinate and other copper salts in the rat and guinea pig.
    Lewis AJ
    Agents Actions; 1978 Apr; 8(3):244-50. PubMed ID: 665434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric mucus effusion elicited by oral copper compounds: potential anti-ulcer activity.
    Rainsford KD; Whitehouse MW
    Experientia; 1976 Sep; 32(9):1172-3. PubMed ID: 9314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of copper complexes as potential anti-arthritic drugs.
    Sorenson JR
    J Pharm Pharmacol; 1977 Jul; 29(7):450-2. PubMed ID: 19591
    [No Abstract]   [Full Text] [Related]  

  • 6. The pharmacologic activity of complexes and mixtures with copper and salicylates or aminopyrine following oral dosing in rats.
    Korolkiewicz Z; Hać E; Gagało I; Gorczyca P; Lodzińska A
    Agents Actions; 1989 Mar; 26(3-4):355-9. PubMed ID: 2735226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of inflammation and gastric damage in rats by copper (II) complexes.
    Jiménez-Hernández RM; Frechilla D; Lasheras B; Gutiérrez-Ríos MT; Parrondo E; Craciunescu G; Cenarruzabeita E
    Arzneimittelforschung; 1995 Mar; 45(3):277-81. PubMed ID: 7741784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copper distribution and reactivity in serum following administration of cuprous oxide to rats and guinea pigs.
    Brown DH; Dunlop J; Smith WE; Teape J
    Agents Actions; 1979 Dec; 9(5-6):575-80. PubMed ID: 546180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of drugs on four paw oedema models in the rat.
    Gemmell DK; Cottney J; Lewis AJ
    Agents Actions; 1979 Apr; 9(1):107-16. PubMed ID: 157060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Species differences in susceptibility to the gastro-ulcerogenic action of anti-inflammatory agents.
    Wilhelmi G
    Pharmacology; 1974; 11(4):220-30. PubMed ID: 4460013
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis, Characterization and Comparison of Local Analgesic, Anti-Inflammatory, Anti-Ulcerogenic Activity of Copper and Zinc Complexes of Indomethacin.
    Sukul A; Poddar SK; Haque S; Saha SK; Das SC; Al Mahmud Z; Abdur Rahman SM
    Antiinflamm Antiallergy Agents Med Chem; 2017; 15(3):221-233. PubMed ID: 28215165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-edema activity of a trans-cutaneous non-steroidal anti-inflammatory agent, etofenamate gel, in rats].
    Nakamura H; Motoyoshi S; Yokoyama Y; Kadokawa T; Shimizu M
    Nihon Yakurigaku Zasshi; 1982 Aug; 80(2):169-82. PubMed ID: 7173740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiinflammatory activity of aqua(cresoxyacetato)-copper(II) complexes.
    Blahová M; Sokolík J; Tumová I; Svec P
    Pharmazie; 1999 Feb; 54(2):156. PubMed ID: 10084161
    [No Abstract]   [Full Text] [Related]  

  • 14. An in vivo, ex vivo and in vitro comparative study of activity of copper oligopeptide complexes vs Cu(II) ions.
    Ciuffi M; Cellai C; Franchi-Micheli S; Zilletti L; Ginanneschi M; Chelli M; Papini AM; Paoletti F
    Pharmacol Res; 1998 Oct; 38(4):279-87. PubMed ID: 9774491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the mechanism of the anti-inflammatory activity of some copper (II) complexes.
    Frechilla D; Lasheras B; Ucelay M; Parrondo E; Craciunescu G; Cenarruzabeitia E
    Arzneimittelforschung; 1990 Sep; 40(9):1008-10. PubMed ID: 1964381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonsteroidal antiinflammatory agents-part 2 antiinflammatory, analgesic and antipyretic activity of some substituted 3-pyrazolin-5-ones and 1,2,4,5,6,7-3H-hexahydroindazol-3-ones.
    El-Hawash SA; Badawey el-SA; El-Ashmawey IM
    Eur J Med Chem; 2006 Feb; 41(2):155-65. PubMed ID: 16375992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipophilic copper(II) formulations: some correlations between their composition and anti-inflammatory/anti-arthritic activity when applied to the skin of rats.
    Beveridge SJ; Whitehouse MW; Walker WR
    Agents Actions; 1982 Apr; 12(1-2):225-31. PubMed ID: 7080960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal toxicity, antiinflammatory activity, and superoxide dismutase activity of copper and zinc complexes of the antiinflammatory drug indomethacin.
    Dillon CT; Hambley TW; Kennedy BJ; Lay PA; Zhou Q; Davies NM; Biffin JR; Regtop HL
    Chem Res Toxicol; 2003 Jan; 16(1):28-37. PubMed ID: 12693028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiinflammatory and antianaphylactic action of vitamins K1 and K3.
    Görög P; Kovács IB; Szporny L; Fekete G
    Arzneimittelforschung; 1968 Feb; 18(2):227-30. PubMed ID: 5695386
    [No Abstract]   [Full Text] [Related]  

  • 20. 6,11-Dihydro-11-oxodibenz [b,e] oxepinacetic acids with potent antiinflammatory activity.
    Ueno K; Kubo S; Tagawa H; Yoshioka T; Tsukada W
    J Med Chem; 1976 Jul; 19(7):941-6. PubMed ID: 940112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.